help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gao, J.
Right arrow Articles by Tseng, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gao, J.
Right arrow Articles by Tseng, L.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
Molecular Endocrinology 14 (12): 1954-1961
Copyright © 2000 by The Endocrine Society

Ligand-Activated Progesterone Receptor Isoform hPR-A Is a Stronger Transactivator Than hPR-B for the Expression of IGFBP-1 (Insulin-Like Growth Factor Binding Protein-1) in Human Endometrial Stromal Cells

Jiaguo Gao, James Mazella, Meiyi Tang and Linda Tseng

Department of Obstetrics/Gynecology and Reproductive Medicine School of Medicine State University of New York at Stony Brook Stony Brook, New York 11794

In human endometrium, the levels of progesterone receptor (PR) isoforms hPR-A and hPR-B are differentially regulated during the reproductive cycle. Progesterone significantly increases the content of hPR-A, the predominant isoform in decidualized stromal cells (1). The purpose of this study was to determine the capacity of hPR-A and hPR-B to transactivate the progestin-dependent target gene in human endometrial stromal cells. We examined the effect of cotransfection of hPR-A or hPR-B on the expression of the human insulin-like growth factor binding protein-1 (IGFBP-1) in endometrial stromal cells. The primary culture of human endometrial stromal cells was transfected with the hPR-A or hPR-B expression vector and the IGFBP-1 promoter construct p275CAT, which contains two functional progesterone response elements (PRE1 and PRE2) in decidualized stromal cells. Medroxyprogesterone acetate (MPA) increased the promoter activities ranging from 1.2- to 27-fold in cells cotransfected with hPR-A or hPR-B in eight endometrial specimens. The promoter activity increased by the hPR-A was significantly higher than hPR-B (15 ± 8 vs. 4 ± 2, mean ± SD; n = 8, P < 0.005). Site-specific mutation showed that the induced activity by hPR-A was mediated through the PRE1 and PRE2 sites. Addition of hPR-B reduced the effect of hPR-A. The high transactivation capacity of hPR-A was also activated by other ligands, progesterone, Org 2058, and norethindrone. These observations indicate that hPR-A is a stronger transactivator than hPR-B for the IGFBP-1 promoter in endometrial stromal cells.

Previous studies have shown the progestin- dependent production of IGFBP-1 correlates with its mRNA levels and transcription rate. Thus, we have determined the effect of hPR-A and hPR-B on the production of IGFBP-1 in stromal cells treated with MPA. The production rate in cells uniformly infected with AdPRA (recombinant Ad5- directed PR expression system) was significantly higher (P < 0.001) than the rate in uninfected cells and in cells infected with AdPRB or AdCMV (the Ad5 viral expression vector). This result, in concert with the promoter analysis, provides evidence that hPR-A is a strong inducer for the chromosomal IGFBP-1 gene in endometrial stromal cells.




This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
B. M. Jacobsen, P. Jambal, S. A. Schittone, and K. B. Horwitz
ALU Repeats in Promoters Are Position-Dependent Co-Response Elements (coRE) that Enhance or Repress Transcription by Dimeric and Monomeric Progesterone Receptors
Mol. Endocrinol., July 1, 2009; 23(7): 989 - 1000.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
M. D Rudd, I. Gonzalez-Robayna, I. Hernandez-Gonzalez, N. L Weigel, W. E Bingman III, and J. S Richards
Constitutively active FOXO1a and a DNA-binding domain mutant exhibit distinct co-regulatory functions to enhance progesterone receptor A activity
J. Mol. Endocrinol., June 1, 2007; 38(6): 673 - 690.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. A. Merlino, T. N. Welsh, H. Tan, L. J. Yi, V. Cannon, B. M. Mercer, and S. Mesiano
Nuclear Progesterone Receptors in the Human Pregnancy Myometrium: Evidence that Parturition Involves Functional Progesterone Withdrawal Mediated by Increased Expression of Progesterone Receptor-A
J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1927 - 1933.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. C. Jones, L. Fusi, J. H. Higham, H. Abdel-Hafiz, K. B. Horwitz, E. W.-F. Lam, and J. J. Brosens
Regulation of the SUMO pathway sensitizes differentiating human endometrial stromal cells to progesterone
PNAS, October 31, 2006; 103(44): 16272 - 16277.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
W. Zhang, J. Mazella, H. J. Kloosterboer, and L. Tseng
Progestagenic Effects of Tibolone are Target Gene--Specific In Human Endometrial Cells
Reproductive Sciences, September 1, 2006; 13(6): 459 - 465.
[Abstract] [PDF]


Home page
EndocrinologyHome page
A. H. Taylor, P. C. McParland, D. J. Taylor, and S. C. Bell
The Progesterone Receptor in Human Term Amniochorion and Placenta Is Isoform C
Endocrinology, February 1, 2006; 147(2): 687 - 693.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
J. L. Turgeon, D. P. McDonnell, K. A. Martin, and P. M. Wise
Hormone Therapy: Physiological Complexity Belies Therapeutic Simplicity
Science, May 28, 2004; 304(5675): 1269 - 1273.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Wu, J. Richer, K. B. Horwitz, and S. M. Hyder
Progestin-Dependent Induction of Vascular Endothelial Growth Factor in Human Breast Cancer Cells: Preferential Regulation by Progesterone Receptor B
Cancer Res., March 15, 2004; 64(6): 2238 - 2244.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
V. C. L. Lin, C. T. Woon, S. E. Aw, and C. Guo
Distinct Molecular Pathways Mediate Progesterone-Induced Growth Inhibition And Focal Adhesion
Endocrinology, December 1, 2003; 144(12): 5650 - 5657.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Ouatas, D. Halverson, and P. S. Steeg
Dexamethasone and Medroxyprogesterone Acetate Elevate Nm23-H1 Metastasis Suppressor Gene Expression in Metastatic Human Breast Carcinoma Cells: New Uses for Old Compounds
Clin. Cancer Res., September 1, 2003; 9(10): 3763 - 3772.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X.-L. Zhang, D. Zhang, F. J. Michel, J. L. Blum, F. A. Simmen, and R. C. M. Simmen
Selective Interactions of Kruppel-like Factor 9/Basic Transcription Element-binding Protein with Progesterone Receptor Isoforms A and B Determine Transcriptional Activity of Progesterone-responsive Genes in Endometrial Epithelial Cells
J. Biol. Chem., June 6, 2003; 278(24): 21474 - 21482.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. A. Patel, J. W. Funder, and J. R. G. Challis
Mechanism of Cortisol/Progesterone Antagonism in the Regulation of 15-Hydroxyprostaglandin Dehydrogenase Activity and Messenger Ribonucleic Acid Levels in Human Chorion and Placental Trophoblast Cells at Term
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2922 - 2933.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Sakai, T. Maruyama, R. Sakurai, H. Masuda, Y. Yamamoto, A. Shimizu, I. Kishi, H. Asada, S. Yamagoe, and Y. Yoshimura
Involvement of Histone Acetylation in Ovarian Steroid-induced Decidualization of Human Endometrial Stromal Cells
J. Biol. Chem., May 2, 2003; 278(19): 16675 - 16682.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
X. Hu, L. Cherbas, and P. Cherbas
Transcription Activation by the Ecdysone Receptor (EcR/USP): Identification of Activation Functions
Mol. Endocrinol., April 1, 2003; 17(4): 716 - 731.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
L. Cherbas, X. Hu, I. Zhimulev, E. Belyaeva, and P. Cherbas
EcR isoforms in Drosophila: testing tissue-specific requirements by targeted blockade and rescue
Development, March 2, 2003; 130(2): 271 - 284.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
X. Qiu, X. Sun, A. Christow, B. Stabi, and K. Gemzell-Danielsson
The effect of mifepristone on the expression of insulin-like growth factor binding protein-1, prolactin and progesterone receptor mRNA and protein during the implantation phase in human endometrium
Mol. Hum. Reprod., November 1, 2002; 8(11): 998 - 1004.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
G. J. Haluska, T. R. Wells, J. J. Hirst, R. M. Brenner, D. W. Sadowsky, and M. J. Novy
Progesterone receptor Localization and Isoforms in Myometrium, Decidua, and Fetal Membranes From Rhesus Macaques: Evidence for Function Progresterone Withdrawal at Parturtion
Reproductive Sciences, May 1, 2002; 9(3): 125 - 136.
[Abstract] [PDF]


Home page
Mol. Endocrinol.Home page
M. Christian, Y. Pohnke, R. Kempf, B. Gellersen, and J. J. Brosens
Functional Association of PR and CCAAT/Enhancer-Binding Protein {beta} Isoforms: Promoter-Dependent Cooperation between PR-B and Liver-Enriched Inhibitory Protein, or Liver-Enriched Activatory Protein and PR-A in Human Endometrial Stromal Cells
Mol. Endocrinol., January 1, 2002; 16(1): 141 - 154.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society